Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen. [electronic resource]
Producer: 20120724Description: 1453-8 p. digitalISSN:- 1460-2091
- Adult
- Antiretroviral Therapy, Highly Active -- adverse effects
- Female
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- administration & dosage
- HIV-1 -- isolation & purification
- Humans
- Male
- Middle Aged
- Retrospective Studies
- Ritonavir -- administration & dosage
- Salvage Therapy -- adverse effects
- Spain
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.